Clinical Trial Update: Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis [Phase 3]

View source ↗

Summary

Phase 3 trial results for roxadustat in anemia associated with chronic kidney disease in non-dialysis patients were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• Roxadustat (roxadustat)

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Anemia in Chronic Kidney Disease in Non-dialysis Patients | Phase 3 | Status: COMPLETED | Results posted: 2020-12-17